Medication type for diabetes may affect severe COVID-19 outcomes
(HealthDay)—The use of certain classes of diabetes medications prior to severe COVID-19 infection is associated with lower mortality in patients […]
» Read moreHome »
Drinking coffee that is caffeinated (ground or instant) or decaffeinated is associated with a reduced risk of developing chronic liver […] A new type of therapeutic food specifically designed to repair the gut microbiomes of malnourished children is superior to standard […] Discovering and treating tumors before they spread throughout the body is key for cancer patients to achieve positive outcomes. When […] One blood type may provide some coronavirus protection, study suggests Preliminary results from an ongoing study suggest that those with […] TUESDAY, Dec. 15, 2020 — The earlier in life type 2 diabetes arises, the deadlier it is, a new analysis […] (HealthDay)—Patients presenting with chilblain-like lesions during the COVID-19 pandemic have histologic and biologic patterns of type I interferonopathy, according to […] Researchers have discovered a previously unknown way that pancreatic cells decide how much insulin to secrete. It could provide a […] Patients with Type 2 diabetes often take metformin as first-line therapy to help stabilize their blood glucose. Eventually, some patients […] Children with multiple islet autoantibodies—biological markers of autoimmunity—are more likely to progress to symptomatic type 1 diabetes (T1D) than those […]
Drinking any type of coffee associated with reduced risk of chronic liver disease
For malnourished children, a new type of microbiome-directed food boosts growth
A new type of recyclable: Finding new uses for established drugs
Why type A blood may increase COVID-19 risk
Type 2 Diabetes in Youth Is Especially Unhealthy: Study
Chilblain-like lesions during COVID-19 tied to type I interferonopathy
‘Rewiring’ metabolism in insulin-producing cells may aid type 2 diabetes treatment
Combo-drug treatment for type 2 diabetes remains effective after two years
Autoantibody order, timing predict genetically at-risk children most likely to get type 1 diabetes
